100
Participants
Start Date
May 31, 2004
Primary Completion Date
March 31, 2005
Study Completion Date
March 31, 2005
De Novo Administration of Darbepoetin Alfa
Administration Q2W for 18 weeks. starting dose is 0.75 mcg/kg rounded to the nearest dose: 20, 30, 40, 50, 60, 80, 100, 150, 200 0r 300 mcg. Titrate to maintain Hb within 11.0 - 13.0 g/dL
Lead Sponsor
Amgen
INDUSTRY